Skip to main content
Figure 2 | Genome Medicine

Figure 2

From: MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32

Figure 2

Recurrence risk prediction. (A, D) Kaplan-Meier analysis of recurrence risk (supervised principal components analysis for the 22 and 5 miRNA profiles). (B, E) Kaplan-Meier analysis of recurrence risk for the 22 and 5 miRNA profiles in addition to chemoresponse as a clinical covariate in the model. (C, F) Kaplan-Meier analysis of recurrence risk using both 22 and 5 miRNA profiles and chemoresponse as categorical variables (three-group analysis). (G) 22 miRNA profile. (H) 5 miRNA profile.

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us